
Insilico UAE AI Drug Discovery Deal
Hong Kong-listed Insilico Medicine signed a cooperation agreement with UAE's drug regulator to advance its AI tools in regional drug discovery amid escalating Middle East tensions. Shares rose up to 12.8% intraday, closing 8.6% higher at HK$56.10, outperforming the Hang Seng Index.





